Science – Page 8 – The Media Pub News ™

ENHERTU® demonstrated statistically significant and clinically meaningful improvement in overall survival in patients with HER2 positive metastatic gastric cancer at interim analysis of DESTINY-gastric04 phase 3 trial

March 26, 2025

Phase 3 results confirm the efficacy of Daiichi Sankyo and AstraZeneca’s ENHERTU in second-line metastatic gastric cancer DESTINY-Gastric04 will be unblinded at interim analysis based on the superior efficacy of ENHERTU Results will be shared with global regulatory authorities TOKYO &

Energy & Power, Environment, Local News, Science

NJ Forest Fire Service conducts prescribed burn at Hillside Farm in Hopewell

March 23, 2025

HOPEWELL TOWNSHIP, N.J. — D&R Greenway Land Trust recently planned to work with The New Jersey Forest Fire Service to conduct a prescribed burn on a large field located on Hopewell-Wertsville Road, which is part of the Betty Wold Johnson Hillside Farm

Education, Energy & Power, Environment, News Now!, Science, Weather & Environment

Saving oil and gas companies from climate change: Expert defines a way forward

March 12, 2025

ALBUQUERQUE, N.M. — The oil and gas industry is responsible for 50% of greenhouse gas emissions, but they are taking significant steps toward climate protection, says Dr. Ian Palmer, a solar space scientist turned oilfield engineer. In his new book, How Oil and

Business, Lifestyle, Money & Financial, Science, Technology

Beacon announces partnership with Renovate Robotics

March 11, 2025

HERNDON, Va. — (BUSINESS WIRE) — $becn #Ambition2025 — Beacon (Nasdaq: BECN), the leading publicly-traded specialty wholesale distributor of roofing, waterproofing and related exterior products, announced today a strategic investment and partnership with Renovate Robotics – a pioneer in roofing automation.

Business, Science

AdvanSix announces fourth quarter and full year 2024 financial results

February 23, 2025

4Q24 Sales of $329 million, down 14% versus prior year 4Q24 Earnings Per Share of $0.01; Adjusted Earnings Per Share of $0.09 4Q24 Cash Flow from Operations of $64 million, up $4 million versus prior year Progressing 45Q carbon capture tax credits

Business, Health Care, Science

WELIREG® (belzutifan) receives first European Commission approval for two indications

February 22, 2025

WELIREG is the first and only oral hypoxia-inducible factor-2 alpha inhibitor approved in the European Union RAHWAY, N.J. — (BUSINESS WIRE) — $MRK #MRK — Merck (NYSE: MRK), known as MSD outside of the United States and Canada, on Tuesday

Health Care, Local News, Science

New five-year Sotyktu (deucravacitinib) data shows consistent safety and durable response rates in moderate-to-severe plaque psoriasis

February 17, 2025

No new safety signals observed at Year 5 in the POETYK PSO long-term extension trial, consistent with the established Sotyktu safety profile Following five years of continuous Sotyktu treatment, clinical response was maintained in nearly half of patients for Psoriasis Area and

Health Care, Lifestyle, Local News, Science

UroGen announces results from subgroup analyses of the pivotal ENVISION trial evaluating impact of baseline tumor burden and focality on response to UGN-102

February 16, 2025

Results presented at the American Society of Clinical Oncology’s Genitourinary Cancers Symposium (ASCO GU 2025) Treatment with UGN-102 resulted in durable complete response (CR) rates across subgroups with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC) CR rates were: 82.8% for patients